Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Clinical trial NCT01723228 · COMPLETED
Trial details
- NCT number
- NCT01723228
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-01-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.